The challenge of chronic chikungunya.

[1]  G. Leoncini,et al.  The medicinal chemistry of Chikungunya virus , 2017, Bioorganic & Medicinal Chemistry.

[2]  M. Grobusch,et al.  Long-term sequelae of chikungunya virus disease: A systematic review. , 2017, Travel medicine and infectious disease.

[3]  A. Fauci,et al.  Meeting the Challenge of Epidemic Chikungunya. , 2016, The Journal of infectious diseases.

[4]  Brad A. Goupil,et al.  A Review of Chikungunya Virus-induced Arthralgia: Clinical Manifestations, Therapeutics, and Pathogenesis , 2016, The open rheumatology journal.

[5]  A. Rodríguez-Morales,et al.  The arboviral burden of disease caused by co-circulation and co-infection of dengue, chikungunya and Zika in the Americas. , 2016, Travel medicine and infectious disease.

[6]  C. Deligny,et al.  Brief Report: Management of Chronic Post‐Chikungunya Rheumatic Disease: The Martinican Experience , 2016, Arthritis & rheumatology.

[7]  T. Morrison,et al.  Chronic chikungunya virus musculoskeletal disease: what are the underlying mechanisms? , 2016, Future microbiology.

[8]  C. Jiménez-Canizales,et al.  Estimating the burden of disease and the economic cost attributable to chikungunya, Colombia, 2014. , 2015, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[9]  B. Hoen,et al.  French guidelines for the management of chikungunya (acute and persistent presentations). November 2014. , 2015, Medecine et maladies infectieuses.

[10]  P. Gasque,et al.  [Chronic rheumatic manifestations following chikungunya virus infection: clinical description and therapeutic considerations]. , 2012, Medecine tropicale : revue du Corps de sante colonial.

[11]  K. Krishnamoorthy,et al.  Burden of chikungunya in India: estimates of disability adjusted life years (DALY) lost in 2006 epidemic. , 2009, Journal of vector borne diseases.